The strawberry extract (2.5, 5, and 10%) reduced tumor pathogenesis along with reductions in gene expression of pro-inflammatory markers (i.e., TNFα, IL-1β, IL-6, COX-2, and iNOS) and signaling pathway mediators (i.e., p-PI3K, p-AKT, and p-ERK) [167]. The gene discussed is MAPK1; the disease is neoplasm.